Harry J.M. Groen

Prof.dr.

University Medical Center Groningen

Netherlands

Research Interests

Explore related searches

Professors in Netherlands Professors in Immunology Immunology professors in Netherlands

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Collaborators (15)

Harriet Wikman

Prof.

University Medical Center Hamburg-Eppendorf

GERMANY

View details

André G Uitterlinden

Erasmus University Rotterdam

NETHERLANDS

View details

Martijn Nawijn

Professor in functional genetics of chronic respiratory disease

University Medical Center Groningen

NETHERLANDS

View details

Kristof Cuppens

Hasselt University

BELGIUM

View details

Grigory Sidorenkov

University Medical Center Groningen

NETHERLANDS

View details

Haiyan Zeng

University of Maastricht

NETHERLANDS

View details

Virissa Lenters

University of Amsterdam

NETHERLANDS

View details

David Gallego Ortega

A/Prof

University of Sydney

AUSTRALIA

View details

Richard Kim

University of Sydney

AUSTRALIA

View details

Wataru Fujii

Assistant professor

Kyoto Prefectural University of Medicine

JAPAN

View details

Anke Van den Berg

University of Groningen

NETHERLANDS

View details

Ed Schuuring

University Medical Center Groningen

NETHERLANDS

View details

Klaus Pantel

GERMANY

View details

Zaigham Saghir

Københavns Universitet

DENMARK

View details

Edward B. Garon

University of California

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Harry J.M. Groen

Research Interests

Explore related searches

Contact this professor

Articles (10)

Multi-source data approach for personalized outcome prediction in lung cancer screening

Systemic alterations in neutrophils and their precursors in early-stage chronic obstructive pulmonary disease.

Risk factors for cognitive impairment in radically treated stage III NSCLC: Secondary findings of the NVALT-11 study

Detection and Monitoring of Tumor-Derived Mutations in Circulating Tumor DNA Using the UltraSEEK Lung Panel on the MassARRAY System in Metastatic Non-Small Cell Lung Cancer Patients

Reliability of panel-based mutational signatures for immune-checkpoint-inhibition efficacy prediction in non-small cell lung cancer

Blood platelet RNA profiles do not enable for nivolumab response prediction at baseline in patients with non-small cell lung cancer

Using genomic scars to select immunotherapy beneficiaries in advanced non-small cell lung cancer

Patient-reported outcomes in capmatinib-treated patients with METex14-mutated advanced NSCLC: Results from the GEOMETRY mono-1 study

Safety and tolerability of stereotactic radiotherapy combined with durvalumab with or without tremelimumab in advanced non-small cell lung cancer, the phase I SICI trial

Case report

Collaborators (15)

Harriet Wikman

André G Uitterlinden

Martijn Nawijn

Kristof Cuppens

Grigory Sidorenkov

Haiyan Zeng

Virissa Lenters

David Gallego Ortega

Richard Kim

Wataru Fujii

Anke Van den Berg

Ed Schuuring

Klaus Pantel

Zaigham Saghir

Edward B. Garon

Make your next move.